한국의 줄기세포 시술에 있어서 문제점
Issues Regarding Stem Cell Therapy in Korea
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
This paper examines the current status of, and issues surrounding, stem cell research in Korea. It is noted that ordinary citizens in Korea are being misled into spending large sums of money on unverified claims regarding stem cell research and that procedures are being prepared to protect people from such unverified claims. It is argued that scientists have responsibilities to provide correct information to the public regarding their research results and professional societies should establish a verification system in which the efficacy and safety of stem cell therapy can be assessed accurately. In addition, it is claimed that governmental authorities have a role to play in developing this line research and delivering accurate information on it so that citizens can form more reasonable expectations concerning scientific progress in the area of stem cell research.
Abstract
This paper examines the current status of, and issues surrounding, stem cell research in Korea. It is noted that ordinary citizens in Korea are being misled into spending large sums of money on unverified claims regarding stem cell research and that procedures are being prepared to protect people from such unverified claims. It is argued that scientists have responsibilities to provide correct information to the public regarding their research results and professional societies should establish a verification system in which the efficacy and safety of stem cell therapy can be assessed accurately. In addition, it is claimed that governmental authorities have a role to play in developing this line research and delivering accurate information on it so that citizens can form more reasonable expectations concerning scientific progress in the area of stem cell research.
참고문헌 (28)
- 생물학적 제제 등 허가 및 심사에 관한 규정, , ~, pp.식약청고시 2006-42호
- "Geron's hESC Trial for Spinal Cord Injury: The Risk of Therapeutic Misconception, in hastings center bioethics forum"[URL]
- "Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis", Blood, 109, pp.693~702 (2007)
- "In the intravascular administration of mesenchymal stem cells safe? Mesechymal stem cells and intravital microscopy", Microvascular Research, 77, pp.370~376 (2009)
- Insoo Hyun, "The bioethics of stem cell research and therapy", The Journal of Clinical Investigation, 120(1), pp.71~74 (2010)
- "ISSCR Task Force for the Clinical Translation of Stem Cells. Guidelines for the Clinical Translation of Stem Cells"[URL]
- Lawrence Burns, ""You are our only hope" : Trading metaphorical "magic bullets" for stem cell "superheores"", Theor Med Bioetech, 30, pp.427~442 (2009)
- "Long-term culture of bone marrow-derived human mesenchymal stem cell frequently undergo spontaneous maligrant transformation", Cancer Research, 69, pp.5331~5339 (2009)
- Ninette Amariglio, "Donor derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient", PLos Medicine
- Paul Nightingale, "The Myth of the biotech revolution", Trends in Biotechnology, 22(11), pp.565~569 (2004)
- Pierre Perrot, "Safety concern between autologous fat graft, mesencymal stem cell and osteosarcoma recurrence", PLoS One, 5, pp.e10999~ (2010)
- "자가줄기세포치료제 허가완화 추진 백지화`복지부·식약청과 논의 중단키로 알앤엘바이오 논란중 시기상조, 업계 허가완화 반대", 국무총리실[URL]
- "무분별한 줄기세포 시술에 쐐기 헬스코리아 뉴스"[URL]
- "배아줄기 활용 세포치료제 개발 길 열렸다"[URL]
- "배아줄기세포 임상승인, `식지 않는 찬반 논란`: 윤리성·안전성 문제 대두, 국생위 판단에 불만 제기, 메디파나, 어윤호 기자"[URL]
- 백수진, "줄기세포를 둘러 싼 문제와 과제", 생명윤리정책연구센터 뉴스레터, (40) (2011)
- "세계 첫 자가줄기세포치료제 나오나? 변재일 의원 등 약사법 개정안 국회발의…임상시험 단축이 핵심 이투데이, 곽도흔 기자"[URL]
- "세포의학회 발표에도 알앤엘 줄기세포 여전히 논란:ICMS 사망-줄기세포 직접적 연관성 희박"..검찰조사 결과에 시선:보건당국·전문가"핵심은 무허가 줄기세포 해외시술"이데일리,천승현 기자"[URL]
- "세포치료 불법 임상시험한 의료기관 무더기 조사 뉴시스, 박재붕 기자"[URL]
- 식약청, "응급상황의 임상시험용 의약품 사용승인-세포(성체줄기)치료제 관련", 2011년 천주교 주교회의 발표
- "자가줄기세포치료제 허가절차 간소화 추진 알앤엘바이오 해외시술 논란 후 국무총리실-보건당국 회의식약청, `안전성 검토사항 일부 면제` 등 허가절차 완화 제안, 복지부는 `신중`..향후 규제개혁위서 논의키로, 이데일리, 천승현 기자"[URL]
- "식품의약품 안전청 홈페이지"[URL]
- "식품의약품안전청 고시 제 2008-39호 제 2조(정의) 조항 54", ~
- "줄기세포 신경계질환 효능입증 안돼" 학회, "줄기세포 해외시술시 부작용 확인 어렵다" 주장. 머니투데이, 김명룡"[URL]
- "의약품임상시험계획승인지침 제7조", ~
- 임현우, "응급임상에 대한 윤리적 판단", 한국천주교 주교회의 발표 2011 2월 발표 (2011)
- "작년 줄기세포분야 정부 투자 530억 데일리메드, 최종학 기자"[URL]
- '미래 성장을 견인할 수 있는 국가존망 기술의 발굴'에 대한 보고서, "한국과학기술기획평가원(KISTEP)", ~ (2009)